Roche
ROG.SW
$242.43
Share price
0.09%
Change (1 day)
-21.18%
Change (1 year)
Categories
Revenue for Roche (ROG.SW)
Revenue in 2023: $71.88 B
According to Roche's latest financial reports the company's current revenue (TTM) is $71.88 B. In 2023 the company made a revenue of $71.88 B an increase over the years 2022 revenue that were of $71.24 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Roche from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 | $71.88 B | 0.91% |
| 2022 | $71.24 B | 3.65% |
| 2021 | $68.73 B | 3.89% |
| 2020 | $66.15 B | 4.26% |
| 2019 | $63.45 B | 9.8% |
| 2018 | $57.79 B | 5.58% |
| 2017 | $54.73 B | 10.25% |
| 2016 | $49.64 B | 1.88% |
| 2015 | $48.72 B | 1.49% |
| 2014 | $48.01 B | -8.94% |
| 2013 | $52.72 B | 5.76% |
| 2012 | $49.85 B | 9.97% |
| 2011 | $45.33 B | -10.75% |
| 2010 | $50.80 B | 7.11% |
| 2009 | $47.42 B | 8.43% |
| 2008 | $43.74 B | 7.33% |
| 2007 | $40.75 B | 17.93% |
| 2006 | $34.55 B | 28.04% |
| 2005 | $26.98 B | 4.26% |
| 2004 | $25.88 B | 2.53% |
| 2003 | $25.24 B | -21.78% |
| 2002 | $32.27 B | 0.99% |
| 2001 | $31.95 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $93.02 B | 29.40% | 🇺🇸 USA |
 Novartis NVS | $51.01 B | -29.04% | 🇨🇭 Switzerland |
 Pfizer PFE | $58.49 B | -18.63% | 🇺🇸 USA |
 Abbott Laboratories ABT | $40.10 B | -44.21% | 🇺🇸 USA |
 Amgen AMGN | $28.19 B | -60.79% | 🇺🇸 USA |
 Sanofi SNY | $50.35 B | -29.95% | 🇫🇷 France |
 Becton Dickinson BDX | $19.49 B | -72.89% | 🇺🇸 USA |
 Merck MRK | $60.11 B | -16.38% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $37.84 B | -47.35% | 🇬🇧 UK |